Texas Retina’s Ashkan Abbey, MD, recently presented “Innovation in Retina for the ASC” at the Outpatient Ophthalmic Surgery Society (OOSS) Symposium 2024.
He highlighted the advantages and disadvantages of several recent surgical advancements in the field of retina, including intraoperative optical coherence tomography (iOCT), 3D visualization, gene therapy, the port delivery system (PDS), and encapsulated cell therapy (ECT). Key take-home points included:
- Vitreoretinal surgery volume will continue to increase in ambulatory surgery centers (ASCs) as innovation shifts treatments for common retinal diseases from the clinic to the operating room (OR).
- ASCs must balance the potentially high cost and added administrative burden of these new technologies with the need to provide the highest quality care for retina patients.
About Dr. Abbey
Dr. Abbey is Texas Retina’s Director of Clinical Research for Dallas and cares for patients in our Dallas Mainand Rockwall offices. He also serves on the OOSS Board of Directors. You can learn more about him here.
About the OOSS
OOSS is dedicated exclusively to the ophthalmic-driven ambulatory surgery center (ASC). They work to ensure top-quality patient care and safety in an environment of ever-changing technology and regulation.